DEFB1 and myeloid sarcoma: Taken together, our results revealed that Nos2 overexpression disrupts the intracellular antimicrobial and anti-inflammatory environment by increasing the concentration of NO, decreasing the levels of ROS and Defb1, and resulting in the enhancement of MS pulmonary colonization capacity in mice.